FDA Committee Reviewing Johnson & Johnson COVID-19 Vaccine
The Food and Drug Administration Advisory Committee is expected to approve Johnson & Johnson’s coronavirus vaccine Friday.
This is the last step before the FDA formally grants authorization for the vaccine.
Unlike the two other approved vaccines being used in the U.S., the Johnson & Johnson vaccine only requires one dose.
Johnson & Johnson has agreed to provide 20 million doses by the end of the month and 100 million by June.